Purchase Order 75N91020P00128

<p>The National Cancer Institute awarded a purchase order to Miltenyi Biotec, Inc., for $16,626.00 on January 7, 2020, with an ultimate completion date of February 7, 2021. The order covers a maintenance agreement on firm fixed price terms. No set-aside was used. Place of performance is Auburn, California.</p>

<p>The National Cancer Institute awarded a purchase order to Miltenyi Biotec, Inc. for $14,631.00 on June 18, 2020. The order procures biological and reagent materials and carries no set-aside designation. Performance occurs in Auburn, California. The ultimate completion date is July 19, 2020. Firm fixed price applies.</p>

<p>The National Cancer Institute awarded a purchase order to Miltenyi Biotec, Inc. for $24,980.62 on July 27, 2020, for scientific equipment with an ultimate completion date of August 31, 2020. No set-aside was used. Performance occurs in Auburn, California. The order procures specialized biotechnology equipment and reagents for cell separation, analysis, and processing technologies that support biomedical research and cell therapy development. Pricing is firm fixed price.</p>

<p>The National Cancer Institute awarded a purchase order to Miltenyi Biotec, Inc. valued at $22,685.00 for scientific equipment with heaters, with an award date of March 12, 2021 and ultimate completion date of April 12, 2021. Place of performance is Auburn, California. The order is firm fixed price with no set-aside designation.</p>

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $24,806.85 firm fixed price purchase order to Miltenyi Biotec, Inc. for equipment. The place of performance will be in Auburn, California, and the period of performance is from November 8, 2023 through December 26, 2023. This purchase order was awarded under the National Cancer Institute's research programs to procure equipment that will support the agency's efforts to advance cancer...

The Department of Health and Human Services National Institutes of Health National Cancer Institute (HHS-NIH-NCI) awarded a $24,806.85 firm fixed price purchase order to Miltenyi Biotec, Inc. for laboratory equipment. The place of performance is Auburn, California and the period of performance is from September 12, 2023 through October 12, 2023. The National Cancer Institute conducts and supports research aimed at discovering prevention and cures for cancer. This purchase order for laboratory...

<p>The National Cancer Institute awarded a purchase order to Miltenyi Biotec, Inc., valued at $25,881.00, on September 15, 2020, for one GentleMACS Octo Dissociator with heaters. The order carries a firm fixed price and is due for completion by October 15, 2020. Place of performance is Auburn, California. The procurement originated from a solicitation posted August 17, 2020, and due August 24, 2020, with no small business set-aside applied.</p>

The National Cancer Institute awarded a $45.9K firm fixed-price purchase order to Miltenyi Biotec, Inc. for preventive maintenance services on two MACSQuant multiparameter flow cytometers. The contract was awarded on March 24, 2026, with an ultimate completion date of March 23, 2027, and will be performed at the National Cancer Institute's facility in Bethesda, Maryland. No set-aside designation was used in this procurement, reflecting Miltenyi Biotec's role as a specialized supplier of...

This is a $18,450 firm fixed-price purchase order awarded by the National Cancer Institute (NCI) to Miltenyi Biotec, Inc., a global biotechnology company that provides specialized scientific instruments, reagents, and services to support biomedical research, cell therapy development, and clinical translation. The contract is for a service agreement with a completion date of January 9, 2026. Miltenyi Biotec, which is a foreign-owned, for-profit manufacturer, has extensive experience as a prime...

This is a $19,325 firm-fixed-price purchase order contract awarded by the National Cancer Institute (NCI) to Miltenyi Biotec, Inc. on February 11, 2025. The contract is for a maintenance agreement with a performance period through February 10, 2026. This award does not have a set-aside designation. Miltenyi Biotec is a global biotechnology company that provides specialized scientific instruments, reagents, and services to support biomedical research, cell therapy development, and clinical...